The Vaccine Economics Research for Sustainability and Equity (VERSE) project evaluated the status of vaccine coverage and equity status in Afghanistan in 2015.

The Vaccine Economics Research for Sustainability and Equity (VERSE) project evaluated the status of vaccine coverage and equity status in Uganda in 2016.

This document summarizes COVID-19 vaccine safety published studies and survey results in map form. Full results can be found on the VIEW-hub COVID safety module.

This document outlines the methods used in the COVID-19 vaccine safety survey presented in the VIEW-hub COVID safety studies module. 

This document outlines the methods used in the COVID-19 vaccine safety literature review presented in the VIEW-hub COVID safety studies module.

The VIEW-hub report displays data and figures on the introduction, use, and coverage status of typhoid conjugate, human papillomavirus, pneumococcal, rotavirus, Hib, and inactivated polio vaccines both globally and in the 54 Gavi countries.

In partnership with the Asian Development Bank, IVAC summarized the evidence for COVID-19 vaccine performance against Omicron sub-variants.

This document provides an overview of the available laboratory evidence on the ability of the bivalent Omicron-containing mRNA COVID-19 vaccines to neutralize Omicron subvariants.

These forest plots summarize the available evidence on the vaccine effectiveness of the bivalent Omicron-containing mRNA COVID-19 vaccines.

In partnership with the Asian Development Bank, IVAC developed factsheets summarizing key measures for COVID-19 vaccines such as effectiveness and protection against severe disease.